学术活动

ACADEMIC ACTIVIYTIES
Image

TBSI湾区智荟讲堂第五十七讲丨科研研讨会【南山智园】

  1. 报告主题:Novel targeted therapeutics for use in cancer
  2. 报告人:Dr. Vijay K. Pandey
  3. 主持:

注:本讲座为计入学分的科研研讨会(Research Seminar)

时间

————————————

2018年10月16日(周二) 1:30-2:30 p.m.


报告摘要

————————————

Targeted therapies, which block the growth and spread of cancer cells by targeting specific molecules required for tumour development and progression, are currently one of the most exciting prospects for the treatment of cancer. Dr Vijay’s research focuses on the discovery of novel secreted or membrane-bound (transmembrane) therapeutic targets for the treatment of human malignancies

BCL-2 associated death promoter (BAD) is a common and core downstream molecule for both the RAS/MAP Kinase and PI3K/AKT/mTOR pathways and which regulates cancer cell survival. In its unphosphorylated state, BAD sequesters BCL-2, which results in BAK/BAX activation and apoptosis. We have identified and characterised a novel small molecule which specifically inhibits BAD phosphorylation on Ser99. This molecule may therefore be therapeutically useful, either alone or in combination to delay or obviate development of resistance to other therapeutic agents.


报告人简介

————————————

Dr. Vijay Pandey is Senior Research Scientist at the Tsinghua-Berkeley Shenzhen Institute (TBSI), China. Prior to current position, Dr Vijay was a Research Fellow at the Cancer Science Institute of Singapore, National University of Singapore. He obtained a doctoral degree (PhD) in Molecular Medicine from the University of Auckland, New Zealand. His primary research interest is directed toward understanding the basis of molecular signatures and their significance in the development of human malignancies. He has led multiple projects that have successfully designed, synthesized, and identified lead candidates for anticancer therapy. Dr Vijay has published multiple peer-reviewed research articles as first author in leading international journals in the field such as Breast Cancer Research, Endocrinology, Medicine, Cell Death & Disease (Nature) and PNAS (USA).


参与方式

————————————

欢迎TBSI各研究中心师生、社会公众及产业界人士参加。校外人员请扫描下方二维码登记信息(姓名、单位、联系电话、身份证号)。讲座语言为英文。